Free Trial

Centrica (CNA) Stock Forecast & Price Target

GBX 137.95
+0.15 (+0.11%)
(As of 07/17/2024 ET)

Centrica - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 6 Wall Street analysts who have issued ratings for Centrica in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 6 analysts, 1 has given a sell rating, and 5 have given a buy rating for CNA.

Consensus Price Target

GBX 171.25
High ForecastGBX 190
Average ForecastGBX 171.25
Low ForecastGBX 155

According to the 6 analysts' twelve-month price targets for Centrica, the average price target is GBX 171.25. The highest price target for CNA is GBX 190, while the lowest price target for CNA is GBX 155. The average price target represents a forecasted upside of 24.14% from the current price of GBX 137.95.

TypeCurrent Forecast
7/18/23 to 7/17/24
1 Month Ago
6/18/23 to 6/17/24
3 Months Ago
4/19/23 to 4/18/24
1 Year Ago
7/18/22 to 7/18/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
5 Buy rating(s)
Hold
0 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetGBX 171.25GBX 164GBX 156.25GBX 137.60
Get Centrica Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CNA and its competitors with MarketBeat's FREE daily newsletter.

CNA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CNA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Centrica Stock vs. The Competition

TypeCentricaUtilities Companies
Consensus Rating Score
2.67
2.46
Consensus RatingModerate BuyHold
News Sentiment RatingPositive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/5/2024JPMorgan Chase & Co.
3 of 5 stars
 Reiterated RatingOverweight
6/28/2024Berenberg Bank
2 of 5 stars
 UpgradeBuyGBX 130 ➝ GBX 155+12.16%
5/31/2024Royal Bank of Canada
4 of 5 stars
 UpgradeOutperformGBX 145 ➝ GBX 170+20.10%
5/15/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweightGBX 205 ➝ GBX 190+31.81%
5/8/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeBuyGBX 165 ➝ GBX 170+26.82%
2/16/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy
6/13/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuyGBX 130+10.59%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:48 PM ET.

CNA Forecast - Frequently Asked Questions

What is Centrica's forecast for 2024?

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Centrica is GBX 171.25, with a high forecast of GBX 190 and a low forecast of GBX 155.

Should I buy or sell Centrica stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Centrica in the last year. There is currently 1 sell rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CNA shares.

Does Centrica's stock price have much upside?

According to analysts, Centrica's stock has a predicted upside of 22.77% based on their 12-month stock forecasts.

Has Centrica been upgraded by Wall Street analysts recently?

Over the previous 90 days, Centrica's stock had 3 upgrades by analysts.

What analysts cover Centrica?

Centrica has been rated by research analysts at Barclays, Berenberg Bank, JPMorgan Chase & Co., Royal Bank of Canada, and UBS Group in the past 90 days.

Do Wall Street analysts like Centrica more than its competitors?

Analysts like Centrica more than other "utilities" companies. The consensus rating for Centrica is Moderate Buy while the average consensus rating for "utilities" companies is Hold. Learn more on how CNA compares to other companies.


This page (LON:CNA) was last updated on 7/17/2024 by MarketBeat.com Staff

From Our Partners